Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

The Oncology Institute, Inc. - Common Stock (NQ: TOI )

0.5258 -0.0051 (-0.96%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 26, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 113,564
Open 0.5500
Bid (Size) 0.5250 (10)
Ask (Size) 0.5258 (5)
Prev. Close 0.5309
Today's Range 0.5100 - 0.5570
52wk Range 0.4070 - 2.655
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
The Oncology Institute Announces Second Quarter 2024 Earnings Release Date and Conference Call
From Toi Management, LLC
Via GlobeNewswire
Why NIO Shares Are Trading Lower By Over 8%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Shares of NIO Inc. (NYSE:NIO) fell sharply during Friday's session after the company disclosed that Steven Wei Feng has resigned as the Chief Financial Officer for personal and family 
Via Benzinga

Performance

YTD
-77.14%
-77.14%
1 Month
+24.19%
+24.19%
3 Month
-55.44%
-55.44%
6 Month
-74.72%
-74.72%
1 Year
-45.70%
-45.70%

More News

Read More
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Recap: Oncology Institute Q4 Earnings
Via Benzinga
Earnings Outlook For The Oncology Institute
Via Benzinga
The Oncology Institute to Participate at Upcoming Investor Conferences
From Toi Management, LLC
Via GlobeNewswire
The Oncology Institute Executives to Participate in Multiple Panel Presentations at APG 2024 Spring Conference
From Toi Management, LLC
Via GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Why Bolt Biotherapeutics Shares Are Trading Lower By Around 34%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
TOI Stock Earnings: The Oncology Institute Misses EPS, Misses Revenue for Q1 2024
Via InvestorPlace
The Oncology Institute Reports First Quarter 2024 Financial Results and Reaffirms Full Year 2024 Guidance
From Toi Management, LLC
Via GlobeNewswire
The Oncology Institute to Participate in Panel Discussion at the Leerink Healthcare Transformation Summit
From Toi Management, LLC
Via GlobeNewswire
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
The Oncology Institute Announces First Quarter 2024 Earnings Release Date and Conference Call
From Toi Management, LLC
Via GlobeNewswire
Jordan McInerney Appointed as Chief Development Officer of The Oncology Institute
From Toi Management, LLC
Via GlobeNewswire
The Oncology Institute and Healthly Forge Strategic Alliance to Elevate Cancer Care Access to Healthly Patients Across Southern California
From Toi Management, LLC
Via GlobeNewswire
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
TOI Stock Earnings: The Oncology Institute Misses EPS, Beats Revenue for Q4 2023
Via InvestorPlace
The Oncology Institute Reports Fourth Quarter and Full Year 2023 Financial Results and Guidance for 2024
From Toi Management, LLC
Via GlobeNewswire
Earnings Scheduled For March 27, 2024
Via Benzinga
MaxHealth & The Oncology Institute Expand Value-Based Care Partnership
From Toi Management, LLC
Via GlobeNewswire
The Oncology Institute Announces Fourth Quarter and Full Year 2023 Earnings Release Date and Conference Call
From Toi Management, LLC
Via GlobeNewswire
The Oncology Institute to Participate at Upcoming Investor Conferences
From Toi Management, LLC
Via GlobeNewswire
Carrum Health and The Oncology Institute Partner on Breast Cancer Treatment Model
From Toi Management, LLC
Via GlobeNewswire
WellBe Senior Medical Partners with The Oncology Institute to Extend High-Value Cancer Care Services Across Illinois and Ohio
From Toi Management, LLC
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.